Alithea Genomics Blog

Search area of interest

26 Mar 2025

Missed Toxicity Signals? Unclear Mechanisms of Action? Can MERCURIUS™ DRUG-seq and Cell Painting De-Risk Drug Discovery?

For researchers performing drug discovery, drug repurposing, toxicogenomic screens, or CRISPR screen...

Written by Daniela Cabuzu

Drug Discovery
DRUG-seq
Cell Painting

18 Mar 2025

Can Combining Cell Painting and L1000 Accelerate Drug Discovery?

Large-scale perturbational profiling is time and cost-intensive, so it’s crucial to compare the capa...

Written by Daniela Cabuzu

L1000
DRUG-seq
Cell Painting

04 Mar 2025

TempO-seq VS DRUG-seq in Compound Screening

Understanding the transcriptomic impacts of new compounds on cells is essential in drug development ...

Written by Daniela Cabuzu

TempO-Seq
DRUG-seq

04 Feb 2025

DRUG-seq for CRISPR screens

In recent years, the convergence of CRISPR gene editing and high-throughput screening methodologies ...

Written by Riccardo Dainese

DRUG-seq

30 Sep 2024

Using External RNA Controls Consortium (ERCC) Molecules Enhances Quality Controls and Biological Interpretation in MERCURIUS™ DRUG-seq

MERCURIUS™ DRUG-seq is a rapid, cost-effective, RNA-extraction-free bulk 3’ mRNA-seq method. It prov...

Written by Alexandre Coudray

Blog
DRUG-seq
ERCC

02 Nov 2023

Probe-based gene expression profiling versus MERCURIUS™ DRUG-seq

Probe-based gene expression profiling methods, such as Affymetrix™ GeneChip™ microarrays, QuantiGene...

Written by Daniela Cabuzu

Blog
Clariom Assay
DRUG-seq
Affymetrix GeneChip
QuantiGene Plex

11 Oct 2023

The Clariom™ GO Screen versus MERCURIUS™ DRUG-seq

Microarray-based Clariom™ assays from Applied Biosystems™ are a potential option for gene expression...

Written by Daniela Cabuzu

Blog
Clariom Assay
DRUG-seq

02 Oct 2023

How does MERCURIUS™ DRUG-seq compare to TempO-Seq™ and RASL-seq?

Determining the transcriptomic effects of novel compounds on cells for large-scale therapeutic or to...

Written by Daniela Cabuzu

Blog
RASL-seq
TempO-Seq
DRUG-seq

10 Jul 2023

How Does RASL-seq Compare to BRB-seq and DRUG-seq

Determining the most suitable transcriptomic technology to drive your large-scale compound screen, c...

Written by Daniela Cabuzu

Tutorials
Blog
RASL-seq
DRUG-seq

25 Oct 2022

DRUG-seq: A Validated Method For Drug Discovery

DRUG-seq is a novel high-throughput, cost-effective RNA-seq method for drug discovery (Ye et al., 20...

Written by Daniela Cabuzu

Drug Discovery
Blog
DRUG-seq

18 Oct 2022

What is DRUG-seq and what are its benefits in drug discovery?

DRUG-seq is a cost-effective, high-throughput RNA-seq method for drug discovery (Ye et al., 2018; Li...

Written by Daniela Cabuzu

Drug Discovery
Blog
DRUG-seq

Cells and organoids (Extraction-free)

Purified RNA

Accessories

Cells and Organoids (EXTRACTION-FREE)

PURIFIED RNA

Whole Blood RNA

Cells and organoids (Extraction-free)

Purified RNA

Accessories

Cells and Organoids (EXTRACTION-FREE)

PURIFIED RNA

Whole Blood RNA

Blog & tutorials

Missed Toxicity Signals? Unclear Mechanisms of Action? Can MERCURIUS™ DRUG-seq and Cell Painting De-Risk Drug Discovery?

Can Combining Cell Painting and L1000 Accelerate Drug Discovery?

TempO-seq VS DRUG-seq in Compound Screening

DRUG-seq for CRISPR screens

Using External RNA Controls Consortium (ERCC) Molecules Enhances Quality Controls and Biological Interpretation in MERCURIUS™ DRUG-seq

Probe-based gene expression profiling versus MERCURIUS™ DRUG-seq

The Clariom™ GO Screen versus MERCURIUS™ DRUG-seq

How does MERCURIUS™ DRUG-seq compare to TempO-Seq™ and RASL-seq?

How Does RASL-seq Compare to BRB-seq and DRUG-seq

DRUG-seq: A Validated Method For Drug Discovery

What is DRUG-seq and what are its benefits in drug discovery?

Subscribe to our newsletter

Get in touch